Protection by coffee against somatic genotoxicity in drosophila: Role of bioactivation capacity

Food and Chemical Toxicology

Volumn 34, Issue 1, 1996, Pages 1-14

  Abraham, S K ^a,b   Graf, U ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOCHROME P450; MITOMYCIN; PROTECTIVE AGENT; URETHAN;

ANIMAL EXPERIMENT; ARTICLE; COFFEE; CONTROLLED STUDY; DOSE RESPONSE; DROSOPHILA MELANOGASTER; GENOTOXICITY; LARVA; METABOLIC ACTIVATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTECTION; SOMATIC MUTATION;

EID: 0030038475     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-6915(95)00087-9     Document Type: Article

References (61)

1. Abraham S. K. (1989) Inhibition of in vivo genotoxicity by coffee. Food and Chemical Toxicology 27, 787-792.
2. Abraham S. K. (1991) Inhibitory effects of coffee on the genotoxicity of carcinogens in mice. Mutation Research 262, 109-114.
3. Abraham S. K. (1994) Antigenotoxicity of coffee in the Drosophila assay for somatic mutation and recombination. Mutagenesis 9, 383-386.
4. Aeschbacher H. U. and Jaccaud E. (1990) Inhibition by coffee of nitrosourea-mediated DNA damage in mice. Food and Chemical Toxicology 28, 633-637.
5. Bligh H. F. J., Bartoszek A., Robson C. N., Hickson I. D., Kasper C. B., Beggs J. D. and Wolf C. R. (1990) Activation of mitomycin C by NADPH-cytochrome P450 reductase. Cancer Research 50, 7782-7792.
6. Cederberg H. and Ramel C. (1989) Modification of the effect of bleomycin in the somatic mutation and recombination test in Drosophila melanogaster. Mutation Research 214, 69-80.
7. Dapkus J. and Merrell D. J. (1977) Chromosomal analysis of DDT-resistance in a long-term selected population of Drosophila melanogaster. Genetics 87, 685-697.
8. Delgado-Rodríguez A., Ortiz-Marttelo R., Graf U., Villalobos-Pietrini R. and Gómez-Arroyo S. (1995) Genotoxic activity of environmentally important polycyclic aromatic hydrocarbons and their nitro derivatives in the wing spot test of Drosophila melanogaster. Mutation Research 341, 235-247.
9. Ferguson L. R. (1994) Antimutagens as cancer chemopreventive agents in the diet. Mutation Research 307, 395-410.
10. Feyereisen R. (1993) Cytochrome P450 in insects. In Cytochrome P450. Edited by J. B. Schenkman and H. Gram, pp. 311-324. Springer-Verlag, Berlin.
11. Frei H., Clements J., Howe D. and Würgler F. E. (1992) The genotoxicity of the anti-cancer drug mitoxanthrone in somatic and germ cells of Drosophila melanogaster. Mutation Research 279, 21-33.
12. Frei H. and Würgler F. E. (1988) Statistical methods to decide whether mutagenicity test data from Drosophila assays indicate a positive, negative or inconclusive result. Mutation Research 203, 297-308.
13. Frei H. and Würgler F. E. (1995) Optimal experimental design and sample size for the statistical evaluation of data from somatic mutation and recombination tests (SMART) in Drosophila. Mutation Research. 341, 235-247.
14. Frölich A. and Würgler F. E. (1989) New tester strains with improved high bioactivation capacity for the Drosophila wing spot test. Mutation Research 216, 179-187.
15. Frölich A. and Würgler F. E. (1990a) Drosophila wingspot test: improved detectability of genotoxicity of polycyclic aromatic hydrocarbons. Mutation Research 234, 71-80.
16. Frölich A. and Würgler F. E. (1990b) Genotoxicity of ethyl carbamate in the Drosophila wing spot test: dependence on genotype-controlled metabolic capacity. Mutation Research 244, 201-208.
17. Fuchs S. Y., Spiegelman V. S. and Belitsky G. A. (1994) Inducibility of various cytochrome P450 isozymes by phenobarbital and some other xenobiotics in Drosophila melanogaster. Biochemical Pharmacology 47, 1867-1873.
18. Fuchs S. Y., Spiegelman V. S., Safaev R. D. and Belitsky G. A. (1992) Xenobiotica-metabolizing enzymes and benzo(a)pyrene metabolism in the benzo(a)pyrene-sensitive mutant strain of Drosophila melanogaster. Mutation Research 269, 185-191.
19. Galloway S. M., Perry P. E., Meneses J., Nebert D. W. and Petersen R. A. (1980) Cultured mouse embryos metabolize benzo(a)pyrene during early gestation: genetic differences detectable by sister chromatid exchange. Proceedings of the National Academy of Science of the U.S.A. 77, 3524-3528.
20. Goeptar A. R., Groot E. J., Scheerens H., Commandeur J. N. M. and Vermeulen N. P. E. (1994) Cytotoxicity of mitomycin C and adriamycin in freshly isolated rat hepatocytes: the role of cytochrome P450. Cancer Research 54, 2411-2418.
21. Graf U. (1995) Analysis of the relationship between age of larvae at mutagen treatment and frequency and size of spots in the wing somatic mutation and recombination test in Drosophila melanogaster. Experientia 51, 168-173.
22. Graf U., Alonso Moraga A., Castro R. and Diaz Carrillo E. (1994) Genotoxicity testing of different types of beverages in the Drosophila wing somatic mutation and recombination test. Food and Chemical Toxicology 32, 423-430.
23. Graf U., Badoux M. and Holliger E. (1992a) The carcinogen DAB is highly genotoxic in the improved high bioactivation cross of the Drosophila wing spot test (SMART). Drosophila Information Service 71, 235-236.
24. Graf U., Frei H., Kägi A., Katz A. J. and Würgler F. E. (1989) Thirty compounds tested in the Drosophila wing spot test. Mutation Research 222, 359-373.
25. Graf U., Heo O. and Olvera Ramirez O. (1992b) The genotoxicity of chromium (VI) oxide in the wing spot test of Drosophila melanogaster is over 90% due to mitotic recombination. Mutation Research 266, 197-203.
26. Graf U. and van Schaik N. (1992) Improved high bioactivation cross for the wing somatic mutation and recombination test in Drosophila melanogaster. Mutation Research 271, 59-67.
27. Graf U. and Würgler F. E. (1986) Investigation of coffee in Drosophila genotoxicity tests. Food and Chemical Toxicology 24, 835-842.
28. Graf U., Würgler F. E., Katz A. J., Frei H., Juon H., Hall C. B. and Kale P. G. (1984) Somatic mutation and recombination test in Drosophila melanogaster. Environmental Mutagenesis 6, 153-188.
29. Guengerich F. P. (1988) Interindividual metabolic variation in humans: mechanisms, methods of assessment, and consequences. In Carcinogen Risk Assessment: New Directions in the Qualitative and Quantitative Aspects. Banbury Report No. 31. Edited by R. W. Hart and F. D. Hoerger. pp. 71-79. Cold Spring Harbor Laboratory, New York.
30. Hällström I. (1987) Genetic variation in cytochrome-P450-dependent demethylation in Drosophila melanogaster. Biochemical Pharmacology 36, 2279-2282.
31. Hällström I., Blanck A. and Atuma S. (1984) Genetic variation in cytochrome P-450 and xenobiotic metabolism in Drosophila melanogaster. Biochemical Pharmacology 33, 13-20.
32. IARC (1991) Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 51. Coffee, Tea, Maté, Methylxanthines and Methylglyoxal. p. 513. International Agency for Research on Cancer, Lyon.
33. Jowett T., Wajidi M. F. F., Oxtoby E. and Wolf C. R. (1991) Mammalian genes expressed in Drosophila: a transgenic model for the study of mechanisms of chemical mutagenesis and metabolism. EMBO Journal 10, 1075-1081.
34. Kato T., Takahashi S. and Kikugawa K. (1991) Loss of heterocyclic amine mutagens by insoluble hemicellulose fiber and high-molecular-weight soluble polyphenolics of coffee. Mutation Research 246, 169-178.
35. Katz A. J. (1989) Sodium thiosulfate inhibits cisplatin-induced mutagenesis in somatic tissue of Drosophila. Environmental and Molecular Mutagenesis 13, 97-99.
36. Komori M., Kitamura R., Fukuta H., Inoue H., Baba H., Yoshikawa K. and Kamataki T. (1993) Transgenic Drosophila carrying mammalian cytochrome P-4501A1: an application to toxicology testing. Carcinogenesis 14, 1683-1688.
37. Lindsley D. L. and Zimm G. G. (1992) The Genome of Drosophila melanogaster. p. 1133. Academic Press, San Diego.
38. Lush I. E. (1981) Mouse pharmacogenetics. In Biology of the House Mouse. Symposia of the Zoological Society of London no. 47. Edited by R. J. Berry, pp. 517-546. Academic Press, London.
39. Morse M. A. and Stoner G. D. (1993) Cancer chemoprevention: principles and prospects. Carcinogenesis 14, 1737-1746.
40. Müller H. and Scott R. (1992) Hereditary conditions in which the loss of heterozygosity may be important. Mutation Research 284, 15-24.
41. Negishi T., Arimoto S., Nishizaki C. and Hayatsu H. (1989) Inhibitory effect of chlorophyll on the genotoxicity of 3-amino-l-methyl-5H-pyrido[4,3-b]indole (Trp-P-2). Carcinogenesis 10, 145-149.
42. Nehlig A. and Debry G. (1994) Potential genotoxic, mutagenic and antimutagenic effects of coffee: a review. Mutation Research 317, 145-162.
43. Olvera O., Zimmering S., Arceo C. and Cruces M. (1993) The protective effects of chlorophyllin in treatments with chromium (VI) oxide in somatic cells of Drosophila. Mutation Research 301, 201-204.
44. Ramel C., Alekperov U. K., Ames B. N., Kada T. and Wattenberg L. W. (1986) Inhibitors of mutagenesis and their relevance to Carcinogenesis. Mutation Research 168, 47-65.
45. Rogers A. E., Zeisel S. H. and Groopman J. (1993) Diet and Carcinogenesis. Carcinogenesis 14, 2205-2217.
46. Schlatter J. and Lutz W. K. (1990) The carcinogenic potential of ethyl carbamate (urethane): risk assessment at human dietary exposure levels. Food and Chemical Toxicology 28, 205-211.
47. Sengstag C. (1994) The role of mitotic recombination in Carcinogenesis. Critical Reviews in Toxicology 24, 323-353.
48. Sladek N. E. (1987) Oxazaphosphorines. In Metabolism and Action of Anticancer Drugs. Edited by G. Powis and R. A. Prough. pp. 48-90. Taylor & Francis, London.
49. Stavric B. (1992) An update on research with coffee/ caffeine (1989-1990). Food and Chemical Toxicology 30, 533-555.
50. Stoewsand G. S., Anderson J. L. and Munson L. (1991) Inhibition by wine of tumorigenesis induced by ethyl carbamate (urethane) in mice. Food and Chemical Toxicology 29, 291-295.
51. Sundseth S. S., Kennel S. J. and Waters L. C. (1989) Monoclonal antibodies to resistance-related forms of cytochrome P450 in Drosophila melanogaster. Pesticide Biochemistry and Physiology 33, 176-188.
52. Sundseth S. S., Nix C. E. and Waters L. C. (1990) Isolation of insecticide resistance-related forms of cytochrome P450 from Drosophila melanogaster. Biochemical Journal 265, 213-217.
53. van Schaik N., Grant A., Rubenchik I. and Graf U. (1984) Use of Drosophila test systems for genotoxicity testing of herbal teas. Immunology and Hematology Research 3, 199-202.
54. Waters L. C., Nix C. E. and Epler J. L. (1983) Studies on the relationship between nitrosamine-demethylase activity and dimenthylnitrosamine-dependent mutagenesis in Drosophila melanogaster. Chemico-Biological Interactions 45, 55-66.
55. Waters L. C., Simms S. I. and Nix C. E. (1984) Natural variation in the expression of cytochrome P-450 and dimethylnitrosamine demethylase in Drosophila. Biochemical and Biophysical Research Communications 123, 907-913.
56. Wattenberg L. W. (1983) Inhibition of neoplasia by minor dietary constituents. Cancer Research 43, 2448-2453.
57. Wattenberg L. W. (1985) Chemoprevention of cancer. Cancer Research 45, 1-8.
58. Weber W. W., Mattano S. S. and Levy G. N. (1988) Acetylation pharmacogenetics: acetylator phenotype and susceptibility to arylamine carcinogenesis. In Carcinogenic Risk Assessment: New Directions in the Qualitative and Quantitative Aspects. Banbury Report No. 31. Edited by R. W. Hart and F. D. Hoerger. pp. 81-92. Cold Spring Harbor Laboratory, New York.
59. Würgler F. E. (1992) Recombination and gene conversion. Mutation Research 284, 3-14.
60. Zijlstra J. A., Vogel E. W. and Breimer D. D. (1983) Strain differences and inducibility of microsomal oxidative enzymes in Drosophila melanogaster. Chemico-Biological Interactions 48, 317-338.
61. Zimmering S., Olvera O., Hernández M. E., Cruces M. P., Arceo C. and Pimentel E. (1990) Evidence for a radioprotective effect of chlorophyllin in Drosophila. Mutation Research 245, 47-49.